Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

14

Full text

11

Free full text

8

Publication Types

Journal Article

14

Research Support, Non-U.S. Gov't

6

Research Support, U.S. Gov't, P.H.S.

5

Research Support, N.I.H., Extramural

5

Review

4

Research Support, U.S. Gov't, Non-P.H.S.

1

Publication Year

From

To

Quick links

Individual year

2020

1

2014

1

2008

3

2007

1

2005

4

2004

2

2003

1

2001

1

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Factor Va""[mesh_terms]

14 Results

Searching titles within these results

Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.

Björn Dahlbäck, Bruno O Villoutreix

Arteriosclerosis, thrombosis, and vascular biology 2005;25(7):1311-20

Proposed structural models of human factor Va and prothrombinase.

C J Lee, P Lin, V Chandrasekaran, R E Duke, S J Everse, L Perera, L G Pedersen

Journal of thrombosis and haemostasis : JTH 2008;6(1):83-9

Cholesterol enhances phospholipid-dependent activated protein C anticoagulant activity.

N M Pecheniuk, H Deguchi, J H Griffin

Journal of thrombosis and haemostasis : JTH 2005;3(2):340-5

Mutation of hydrophobic residues in the factor Va C1 and C2 domains blocks membrane-dependent prothrombin activation.

W H Kane, M A Quinn-Allen, W Peng

Journal of thrombosis and haemostasis : JTH 2005;3(2):351-4

Factor Va residues 311-325 represent an activated protein C binding region.

Subramanian Yegneswaran, Yumi Kojima, Phuong M Nguyen, Andrew J Gale, Mary J Heeb, John H Griffin

The Journal of biological chemistry 2007;282(39):28353-28361

New anticoagulant therapy.

Lori-Ann Linkins, Jeffrey I Weitz

Annual review of medicine 2005;56():63-77

Identification of an inactivating cleavage site for alpha-thrombin on the heavy chain of factor Va.

Evrim Erdogan, Michael A Bukys, Thomas Orfeo, Kenneth G Mann, Michael Kalafatis

Thrombosis and haemostasis 2008;98(5):998-1006

Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.

Mary J Heeb, Rolf M Mesters, José A Fernández, Tilman M Hackeng, Ryon K Nakasone, John H Griffin

Thrombosis and haemostasis 2014;110(2):275-82

Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C.

Andrew J Gale, Xiao Xu, Jean-Luc Pellequer, Elizabeth D Getzoff, John H Griffin

Protein science : a publication of the Protein Society 2003;11(9):2091-101

Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding.

Mettine H A Bos, Pieter H Reitsma, Mark Schreuder

Journal of thrombosis and haemostasis : JTH 2020;17(8):1229-1239

Identification of functionally important residues in proteins using comparative models.

Jean-Luc Pellequer, Shu-Wen W Chen

Current medicinal chemistry 2004;11(5):595-605

Plasma cholesteryl ester transfer protein and blood coagulability.

José A Fernández, Hiroshi Deguchi, John H Griffin

Thrombosis and haemostasis 2008;98(6):1160-4

Anticoagulant dysfunction of human Arg352Trp-activated protein C caused by defective factor Va inactivation.

C Rintelen, S Yegneswaran, J H Griffin

Thrombosis and haemostasis 2001;85(2):274-9

Sphingolipids as bioactive regulators of thrombin generation.

Hiroshi Deguchi, Subramanian Yegneswaran, John H Griffin

The Journal of biological chemistry 2004;279(13):12036-42

Results: 1 – 14 / 14

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.